MacWeb Opens US East Region Cloud Service NY-Metro Data Center

New York-metro deployment brings Apple Mac mini and Mac Studio cloud servers for CI/CD, creative workloads, and Al inference at significantly lower cost than major cloud providers MacWeb, a provider of Mac-based cloud infrastructure for AI inference and iOS application workloads, has launched its US East region cloud service in the New York metropolitan area. […]

Clorox to Present at Morgan Stanley Global Consumer & Retail Conference

The Clorox Company (NYSE: CLX) today announced that Chief Financial Officer Luc Bellet will participate in a fireside chat at the Morgan Stanley Global Consumer & Retail Conference on Tuesday, Dec. 2, 2025, in New York City. The webcast will begin at approximately 2:15 p.m. ET (11:15 a.m. PT) and can be accessed on thecompany's

Jacobs Reports Strong Fiscal Fourth Quarter and Fiscal Year 2025 Earnings

Gross Revenue Grew 6.6% y/y, Adj. Net Revenue Grew 5.8% y/y in Fiscal Fourth Quarter 2025 Backlog Reached New Record with TTM Book-to-Bill Ratio of 1.1x Returned a Record $1.1 billion Through Repurchases and Dividends in Fiscal 2025 Fiscal 2026 Guidance for 16% Growth in Adj. EPS, at Midpoint Jacobs Solutions Inc. (NYSE: J) today

Lost Money on James Hardie Industries plc. (JHX)? Contact Levi & Korsinsky to Join Class Action Before December 23, 2025

NEW YORK, NY / ACCESS Newswire / November 20, 2025 / If you suffered a loss on your James Hardie Industries plc. (NYSE:JHX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/james-hardie-industries-plc-lawsuit-submission-form?prid=178284&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

Liquidity Services Announces Fourth Quarter Fiscal Year 2025 Financial Results

Liquidity Services Announces Fourth Quarter Fiscal Year 2025 Financial Results GlobeNewswire November 20, 2025 Strong Fourth Quarter Fueled by Market Share Expansion and Operating Leverage Annual GMV Surpasses $1.5 Billion Milestone with Record Number of Auction Participants BETHESDA, Md., Nov. 20, 2025 (GLOBE NEWSWIRE) — Liquidity Services (NASDAQ:LQDT; www.liquidityservices.com), the leading global provider of e-commerce

PIEDMONT REALTY TRUST ANNOUNCES RESULTS OF TENDER OFFER FOR ANY AND ALL OF ITS OUTSTANDING 9.250% SENIOR NOTES DUE 2028

PIEDMONT REALTY TRUST ANNOUNCES RESULTS OF TENDER OFFER FOR ANY AND ALL OF ITS OUTSTANDING 9.250% SENIOR NOTES DUE 2028 GlobeNewswire November 20, 2025 Atlanta, Nov. 20, 2025 (GLOBE NEWSWIRE) — Piedmont Realty Trust, Inc. (“Piedmont” or the “Company”) (NYSE: PDM), today announced the results, as of 5:00 p.m., New York City time, on November

Real Matters Reports Fourth Quarter and Fiscal 2025 Financial Results

Real Matters Reports Fourth Quarter and Fiscal 2025 Financial Results GlobeNewswire November 20, 2025 (all amounts are expressed in millions of U.S. dollars, excluding per share amounts and unless otherwise stated) TORONTO, Nov. 20, 2025 (GLOBE NEWSWIRE) — Real Matters Inc. (TSX: REAL) (“Real Matters” or the “Company”), a leading network management services platform for

SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression

(NASDAQ:SPRC),(TSX-V:NTLX),(NASDAQ:CMND), TEL AVIV, Israel, Nov. 20, 2025 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) (“NeuroThera”), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system (CNS) disorders, in which SciSparc holds a controlling interest of approximately 75%, has advanced its collaboration

SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression

SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression GlobeNewswire November 20, 2025 TEL AVIV, Israel, Nov. 20, 2025 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) (“NeuroThera”), a clinical-stage pharmaceutical company focused on developing

KMX ALERT: Securities Fraud Class Action Launched Against CarMax, Inc. – January 2, 2026 Deadline

NEW YORK, NY / ACCESS Newswire / November 20, 2025 / If you suffered a loss on your CarMax, Inc. (NYSE:KMX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/carmax-inc-lawsuit-submission-form?prid=178282&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Scroll to Top